Search research articles
Contact Us
Filters
Showing results (181-190 of 257) with videos related to
Page
of 26
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 8, 2015
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013
Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance Mechanisms
Rodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Journal of Clinical Microbiology
|
May 24, 2013
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents
Rodrigo E Mendes, Lalitagauri M Deshpande, Jihye Kim, et al.
Diagnostic Microbiology and Infectious Disease
|
June 30, 2014
Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine
Rodrigo E Mendes, Andrew J Costello, Michael R Jacobs, et al.
International Journal of Antimicrobial Agents
|
June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
The Pediatric Infectious Disease Journal
|
April 14, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014
Michael A Pfaller, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy
|
August 26, 2021
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Rodrigo E Mendes, Timothy B Doyle, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency
Rodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
July 21, 2017
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
Michael A Pfaller, Helio S Sader, Robert K Flamm, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 257) with videos related to
Sort By:
Page
of 26
Antimicrobial Agents and Chemotherapy
|
April 8, 2015
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013
Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance Mechanisms
Rodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Journal of Clinical Microbiology
|
May 24, 2013
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents
Rodrigo E Mendes, Lalitagauri M Deshpande, Jihye Kim, et al.
Diagnostic Microbiology and Infectious Disease
|
June 30, 2014
Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine
Rodrigo E Mendes, Andrew J Costello, Michael R Jacobs, et al.
International Journal of Antimicrobial Agents
|
June 14, 2016
Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)
Helio S Sader, Mariana Castanheira, David J Farrell, et al.
The Pediatric Infectious Disease Journal
|
April 14, 2017
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014
Michael A Pfaller, Rodrigo E Mendes, Mariana Castanheira, et al.
The Journal of Antimicrobial Chemotherapy
|
August 26, 2021
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Rodrigo E Mendes, Timothy B Doyle, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
May 10, 2015
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia
Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
September 10, 2016
Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency
Rodrigo E Mendes, Mariana Castanheira, David J Farrell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
July 21, 2017
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
Michael A Pfaller, Helio S Sader, Robert K Flamm, et al.
Page
of 26